| Sean N. Tucker |
Sean N. Tucker is the founder of Vaxart, Inc. which was founded in 2004. He held the title of Director & Vice President-Research from 2012 to 2013. He is currently the Chief Scientific Officer & Senior Vice President at Vaxart, Inc. Dr. Tucker also held former positions as Principal at The Dow Chemical Co., Systemix, Inc., and Genteric, Inc. In terms of education, Dr. Tucker obtained undergraduate and doctorate degrees from the University of Washington and a graduate degree from the University of California, Berkeley. |
| Michael J. Finney |
Michael J. Finney was the founder of Addition Therapeutics, a company founded in 2021, where he served as the Board Chair from 2021 to 2023. He is currently the Chairman of Vaxart, Inc. since 2007, the Managing Director of Finney Capital since 2004, and the Director of Orion Genomics LLC since 2019. He also holds director positions at Thrive Bioscience, Inc., seqWell, Inc., KarnaTeq, Inc., S2 Genomics, Inc., and Essen Instruments, Inc. Dr. Finney's former positions include Chief Executive Officer of Vaxart, Inc. from 2009 to 2011, Director of Banyan Energy, Inc. from 2013 to 2016, Director of Innerscope Research, Inc. from 2009 to 2016, Director of PharmaSecure, Inc. in 2009, and Director of Nanotech Biomachines, Inc. and Essen Instruments, Inc. He was also the CSO and Board Director of MJ Research, Inc. from 1985 to 2004, Director of Mission Motor Co. from 2009 to 2010, and Director of Driver Bioengineering, Inc. from 2017 to 2019. Dr. Finney obtained his undergraduate degree from Harvard University in 1980 and his doctorate degree from Massachusetts Institute of Technology in 1987. |
| Phillip Eric Lee |
Phillip Eric Lee's current job is Chief Financial Officer at Vaxart, Inc. His former jobs include Senior Director at Cytokinetics, Inc., Associate Director at Adverum Biotechnologies, Inc., Senior Director & Vice President at 4D Molecular Therapeutics, Inc., and Principal at Centerview Partners LLC. He also served as Chief Financial & Business Development Officer at Clover Biopharmaceuticals Ltd. Mr. Lee obtained his undergraduate degree from the University of California, Berkeley. |
| Raymond D. Stapleton |
Raymond D. Stapleton is currently the President & Chief Operating Officer at International BioResources Group and the Chief Technology Officer at Vaxart, Inc. He was previously the Executive Director-Global Vaccine Technology at Merck & Co., Inc., the President & Chief Operating Officer at American Type Culture Collection, the Chief Technology Officer & Executive VP at Genocea Biosciences, Inc., and the Senior Vice President-Manufacturing at Theriva Biologics, Inc. He also briefly served as the Senior Vice President-Technical Operations at Iovance Biotherapeutics, Inc. Stapleton holds a doctorate from the University of Tennessee and an undergraduate degree from the University of Mary Washington. |
| James F. Cummings |
James F. Cummings is currently the Chief Medical Officer at Vaxart, Inc. Prior to this, he served as the President & CEO at ICON Government & Public Health Solutions, Inc. from 2018 to 2021. He also held positions as Director at OyaGen, Inc., Director-Translational Medicine at Walter Reed Army Institute of Research from 2007 to 2009, Director-Defense Department at Global Emerging Infectious Surveillance & Response System from 2012 to 2015, and VP-Clinical Development & Translational Medicine at Novavax, Inc. from 2015 to 2018. Cummings received his undergraduate degree from Georgetown University School of Medicine. |
| Steven Lo |
Steven Lo's current job is as the President, Chief Executive Officer & Director at Vaxart, Inc. He previously worked as the Chief Executive Officer & Director at Valitor, Inc. from 2022 to 2024, and as the President, Chief Executive Officer & Director at Zosano Pharma Corp. from 2019 to 2022. Prior to that, he held the position of Senior Director-Oncology Marketing at Genentech, Inc. from 1997 to 2010. He also served as the Chief Commercial Officer & Senior Vice President at Corcept Therapeutics, Inc. from 2013 to 2015, and as the Chief Commercial Officer at Puma Biotechnology, Inc. from 2015 to 2019. Mr. Lo's education includes a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Davis. |
| William Mark Watson |
William Mark Watson is currently serving as the Director at GlobalHealth, Inc. He is also an Independent Director at Vaxart, Inc., a Director at Momentum Health Holdings LLC, a Director at H. Lee Moffitt Cancer Center & Research Institute Lifetime, an Independent Trustee at abrdn Healthcare Investors, an Independent Trustee at abrdn Life Sciences Investors, and an Independent Trustee at abrdn World Healthcare Fund. Additionally, he is a Member of The American Institute of Certified Public Accountants, the Florida Institute of Certified Public Accountants, and the New York State Society of Certified Public Accountants. Mr. Watson is the President of WM Watsons LLC and a Trustee at Moffitt Medical Group. In the past, he served as the Chairman of Inhibitor Therapeutics, Inc. from 2019 to 2022. He was also an Independent Director at Sykes Enterprises, Inc. from 2018 to 2021 and an Independent Director at BioDelivery Sciences International, Inc. from 2017 to 2022. Furthermore, he served as a Director at The Florida Aquarium, Inc. and a Trustee at H. Lee Moffitt Cancer Center & Research Institute, Inc. Mr. Watson started his career as the Lead Audit Partner at Deloitte Touche Tohmatsu Ltd. from 1973 to 2013. He obtained his undergraduate degree from Marquette University. |
| David E. Wheadon |
David E. Wheadon is currently the Director at PSKW LLC, Independent Director at Sotera Health Co., Lead Independent Director at Vaxart, Inc., and Independent Non-Executive Director at Indivior PLC. He is also a Member of the American Psychiatric Association, the American Academy of Pharmaceutical Physicians, and a Trustee at The Mount Sinai Health System, Inc. Previously, Dr. Wheadon held positions as Director at Assertio Therapeutics, Inc., Independent Director at ChemoCentryx, Inc., Director-Clinical Research at Smithkline Beecham Pharmaceuticals Ltd., Director at Make-A-Wish Foundation of Illinois, Director at Assertio Holdings, Inc., Independent Director at Karuna Therapeutics, Inc., Senior VP-Global Pharmaceutical Regulatory at Abbott Laboratories, Clinical Research Physician at Eli Lilly & Co., Senior Vice President-Global Regulatory Affairs at AstraZeneca PLC, Senior Vice President-US Regulatory Affairs at GSK Plc, SVP-Global Regulatory Affairs & Patient Safety at AstraZeneca Pharmaceuticals LP, Executive Vice President-Research & Advocacy at JDRF International, Senior VP-Scientific & Regulatory Affairs at Pharmaceutical Research & Manufacturers of America, and Executive Vice President-Research & Advocacy at Juvenile Diabetes Research Foundation. Dr. Wheadon received his undergraduate degree from Harvard University and his doctorate from The Johns Hopkins University School of Medicine. |
| Elaine J. Heron |
Elaine J. Heron's current job(s) include Chairman-Life Science Screening at Kyto Technology & Life Science, Inc., Independent Non-Executive Director at BioMarin Pharmaceutical, Inc., Director at Amplyx Pharmaceuticals, Inc., Director at Zephyrus Biosciences, Inc., Director at Vala Sciences, Inc., Director at Palvella Therapeutics, Inc., Independent Director at Vaxart, Inc., Director at Dropworks, Inc., Director at Aro Biotherapeutics Co., Director at Visgenx, Inc., and Director at Watershed Medical, Inc.Dr. Heron's former job(s) include Chairmen & Chief Executive Officer at Labcyte, Inc., Director-Marketing at Molecular Dynamics, Inc., Director at Insmed, Inc., Director at Fluxion Biosciences, Inc., Director at Bavarian Nordic A, Director at Revolution Medicines, Inc., Director at Context Therapeutics LLC, Vice President at Applied Biosystems, Inc., Vice President-Marketing at Affymetrix, Inc., and General Manager, Vice President-Sales & Marketing at Applera Corp.Dr. Heron's education history includes an MBA from Pepperdine University and undergraduate and doctorate degrees from Purdue University. |
